Facts checked on 2 November 2026.
India mein semaglutide tablets type 2 diabetes ke adults mein blood sugar control ke liye hain, diet aur exercise ke saath1,2. PharmEasy kehta hai ki India mein semaglutide ke sabhi brands Schedule H prescription dawa hain3. Rybelsus, Dr Reddy's ki Obeda aur Torrent ki Semalix aur Sembolic tablets 3, 7 aur 14 mg mein milti hain4,5,6. Wajan kam karne wali semaglutide tablet, yaani Wegovy pill, US mein obesity ya overweight wale adults ke liye approved hai7. Lekin 20 October 2026 tak India mein Wegovy 25 mg pill ka koi approval ya launch nahi mila8. Upar ki in Indian tablets ka approved use obesity nahi hai1,2,8,9.
India mein semaglutide tablets aur doosri GLP-1 tablet: 20 October 2026 tak ka status, report ki gayi tareekhon ke saath. Ye list poori nahi hai4,8,10,11,12.
Facts checked on 2 November 2026.
| Brand | Company | Strengths | India mein use (source) | Status ya tareekh |
|---|---|---|---|---|
| Rybelsus | Novo Nordisk | 3, 7 aur 14 mg | Type 2 diabetes (CDSCO committee, August 2023) | India mein launch January 2022, jaisa report hua1,4,13 |
| Obeda tablets | Dr Reddy's | 3, 7 aur 14 mg | Type 2 diabetes (company launch, as reported) | Launch 20 May 20266,11 |
| Semalix aur Sembolic tablets | Torrent | 3, 7 aur 14 mg | Type 2 diabetes (CDSCO committee, January 2026) | Launch 21 March 20265,9,10 |
| Wegovy pill | Novo Nordisk | US: 1.5 mg se 25 mg tak | US: obesity ya overweight wale adults mein wajan kam karna; India: approval nahi mila | 20 October 2026 tak India mein approval ya launch nahi mila; committee ne 23 September 2026 ko aur data maanga, jaisa report hua7,8,14 |
| Orforglipron (Foundayo), doosri dawa | Lilly | US: 0.8 mg se 17.2 mg tak | US: wajan kam karna | Ye semaglutide nahi hai. CDSCO expert committee ki recommendation June 2026 mein, jaisa report hua; India mein launch nahi mila12,15 |
How this page was checked. Is page mein battees sources hain: CDSCO committee minutes, sarkari pages, ek stock-exchange filing, Indian news aur pharmacy listings, US labels, ek US pharmacy journal aur UK ki NHS guidance. Facts 2 November 2026 ko check kiye gaye. Zelta ke kisi doctor ne abhi tak is page ko review nahi kiya hai.
Semaglutide tablets kya hain aur kis liye di jaati hain
India mein semaglutide tablets ka approved use type 2 diabetes mein blood sugar control hai1,2. CDSCO ki committee ne August 2023 mein Rybelsus ka Indian use yahi likha: adults mein type 2 diabetes, diet aur exercise ke saath1. Torrent ki tablets ke liye bhi committee ne January 2026 mein type 2 diabetes likha, weight management nahi9. Obeda bhi type 2 diabetes ke liye launch hui11. Sun Pharma ki semaglutide tablets ko committee ne June 2026 mein recommend kiya16.
Semalix, Sembolic aur Obeda injection ke naam bhi hain, isliye apne pack par form check karein10,17.
Kya India mein koi semaglutide tablet wajan kam karne ke liye approved hai? Nahi, 20 October 2026 tak aisa approval nahi mila1,2,8,9. India mein weight management wali GLP-1 dawa injection ke roop mein hai18,19. Novo Nordisk India ne Wegovy tablets 1.5, 4, 9 aur 25 mg ke liye CDSCO se permission maangi hai, aisa Medical Dialogues ne 21 October 2026 ko report kiya14. Hamari English guide GLP-1 tablets in India mein poora status hai.
PharmEasy kehta hai ki India mein bikne wali "Glp 1mg Tablet" mein glimepiride 1 mg hai, aur ye GLP-1 dawa nahi hai20. Glimepiride ek sulfonylurea hai, jo blood sugar ko bahut kam kar sakta hai21.
Semaglutide tablet kaise kaam karti hai
GLP-1 ek natural hormone hai, jo khana khaane par aant (gut) ki cells banati hain22. Semaglutide is hormone ke receptor se judkar use chalu karta hai, isliye ise GLP-1 receptor agonist kehte hain7. US label kehta hai ki GLP-1 bhookh aur calorie ko niyantrit karta hai, aur dimaag ke bhookh wale hisson mein iske receptor hain7. GLP-1 dawayein pet ke khaali hone ki speed dheemi karti hain, isliye pet jaldi aur der tak bhara lag sakta hai23.
Rybelsus mein SNAC naam ka ingredient hai, jo semaglutide ko pet se khoon mein jaane mein madad karta hai24. ET Pharma ke anusaar Dr Reddy's ki tablet bhi SNAC use karti hai, jo semaglutide ko pet ke enzymes se bachati hai6. India mein in tablets ka kaam type 2 diabetes mein blood sugar control hai1,2.
Semaglutide tablets kaise lein: label kya kehta hai
US Rybelsus label kehta hai: din mein ek tablet, subah khaali pet, 4 ounces tak paani ke saath, aur koi doosra drink nahi24. NHS ye limit aadha glass paani, yaani 120 ml tak, batata hai25. Tablet ke baad label kam se kam 30 minute rukne ko kehta hai, khana, peena ya doosri dawa lene se pehle24. Label ke hisaab se isme subah ki chai bhi aati hai24. Agar aap subah thyroid ki tablet (levothyroxine) lete hain, to timing apne doctor se puchhein24,25. Tablet poori nigli jaati hai, todi, peesi ya chabayi nahi jaati24.
US label ke anusaar Rybelsus 3 mg se shuru hoti hai, 30 din tak, aur ye dose abhi blood sugar control nahi karti24. Din 31 se 60 tak label 7 mg likhta hai24. Din 61 se dose 7 mg par rehti hai, ya blood sugar ke liye zaroorat ho to 14 mg tak jaati hai24. India ki Rybelsus, Semalix, Sembolic aur Obeda tablets inhi 3, 7 aur 14 mg strengths mein aati hain4,5,6. ET Pharma kehta hai ki Obeda par mareez din mein ek tablet lete hain, aur dose dheere dheere badhti hai6. Label mein chhooti hui dose chhod di jaati hai, aur agli dose agle din li jaati hai24.
Ye US label ka schedule hai, kisi ka personal plan nahi. Aapki dose aapke doctor tay karte hain. Tablet ki dose ko injection ki dose mein na badlein. US label ke hisaab se tablets 20–25 °C par, apni original bottle mein, nami se door rakhi jaati hain24.
Side effects, emergency aur kab turant doctor se milein
US Rybelsus label ke diabetes trials mein sabse aam side effect nausea tha24. Ye 7 mg par 11 % aur 14 mg par 20 % logon ko hua, placebo par 6 % ko24. Dast 9 % aur 10 %, pet dard 10 % aur 11 %, ulti 6 % aur 8 %, aur kabz 6 % aur 5 % logon mein dikhi24. Placebo par ye 4 %, 4 %, 3 % aur 2 % thi24. Gambhir pet ki dikkat 7 mg par 0.6 % aur 14 mg par 2 % mein report hui, placebo par 0.3 %24. Dekhein: semaglutide side effects guide.
Agar aap insulin ya sulfonylurea bhi lete hain, to low blood sugar ka dhyan rakhein. US label kehta hai ki sulfonylurea ya insulin ke saath Rybelsus lene par low blood sugar ka risk badh sakta hai, gambhir low bhi ho sakta hai24. NHS ke hisaab se iske sign hain paseena, kaanpna, dil ki tez dhadkan aur chakkar25. Aise mein turant ilaaj karein, jaise ek chhota glass fruit juice, aur phir doctor ko batayein26.
Turant 112 par call karein, India ka emergency number27:
- Gambhir allergic reaction: gala ya jeebh sooj jaye, khujli wala ubhra hua rash ho, ya saans lene mein dikkat ho25.
- Sugar shayad bahut gir gayi ho, aur insaan theek se react na kare ya hosh kho de26. Jo insaan hosh mein nahi, uske munh mein khana ya paani na dalein26.
Turant doctor se sampark karein ya turant medical madad lein:
- Pet mein tez dard jo nahi jaata, kabhi peeth tak, ulti ke saath ya bina24. Ye pancreatitis ka sign ho sakta hai. US semaglutide (Wegovy) Medication Guide ke mutabik aise mein dawa rokein aur bina der kiye doctor ko phone karein7.
- Achanak nazar jaana, aksar ek aankh mein25.
- Upar pet mein dard, peeli skin ya aankhein, bukhar, ya mitti jaisa halka stool (gallbladder ke sign)7.
- Gambhir kabz, ya aisa lage ki aant ruk gayi hai7,28.
Usi din doctor se sampark karein:
- Ulti itni ki paani bhi andar na rahe, ya dast mein khoon29.
- Nazar mein badlav, agar aapko diabetic eye disease hai25.
Doctor ko batayein: gardan mein gaanth, kuch nigalna mushkil lage, saans phoole, ya aawaaz baithi rahe aur theek na ho24.
Aap khud bhi side effect India ke PvPI ko report kar sakte hain30. Helpline 1800 180 3024 hai, working days par31.
Kaun semaglutide tablets na le
US Rybelsus label ke hisaab se jinke parivaar mein ya khud ko medullary thyroid cancer (MTC) hua ho, ya jinhe MEN 2 ho, wo ye tablets nahi le sakte24. Ye warning rodents (chuhe jaise jaanwaron) par studies se aayi hai, jahan semaglutide se thyroid C-cell tumour hue24. Kya insaanon mein bhi ye khatra hai, ye abhi tak maloom nahi24. US Wegovy label kehta hai ki jinhe semaglutide ya uske kisi ingredient se gambhir allergy hui ho, wo bhi isse nahi le sakte7.
NHS kehta hai ki pregnancy mein semaglutide nahi di jaati; pregnant hon to doctor ko zaroor batayein25. NHS pregnancy plan karne se kam se kam 2 mahine pehle semaglutide band karne ki salah deta hai25. Tablet ke liye US label breastfeeding ke dauran ise na lene ki salah deta hai, kyunki SNAC baby mein jama ho sakta hai24. NHS kehta hai ki agar acute pancreatitis hai ya pehle hua ho, ya semaglutide ya doosri GLP-1 dawa se allergy hui ho, to semaglutide shayad sahi na ho25.
Ye limits US label aur NHS se hain, isliye India mein doctor inhe aapke brand ke leaflet se milate hain. Inmein se kuch bhi aap par laagu ho to doctor ko pehli dose se pehle batayein. Dekhein: who should not take semaglutide.
India mein semaglutide tablets ki keemat
Ye report ki gayi keemat hai, offer nahi. PharmEasy ke 1 October 2026 ke page par Rybelsus ka MRP 10 tablets ki strip ke liye lagbhag ₹2,972 (3 mg), ₹3,300 (7 mg) aur ₹3,628 (14 mg) hai4. PharmEasy kehta hai ki ye MRP hai, selling price isse kam ho sakti hai, aur keemat badalti rehti hai4. Obeda 20 May 2026 ko launch hui11. ET Pharma ke anusaar iski keemat har tablet ₹99 (3 mg), ₹135 (7 mg) aur ₹225 (14 mg) hai6. Torrent ki tablets ki koi dated keemat hamein nahi mili.
Aksar puchhe jaane wale sawal (FAQ)
Rybelsus 3 mg tablet ka kya upyog hai? US label ke anusaar 3 mg Rybelsus ki shuruati dose hai, 30 din ke liye, aur ye dose abhi blood sugar control nahi karti24. Rybelsus khud type 2 diabetes ki dawa hai1.
Sugar ki goli kaise khayi jati hai? Ye jawab sirf semaglutide tablets ke liye hai. Doosri goliyon ke niyam alag ho sakte hain. US label ke anusaar tablet subah khaali pet, 4 ounces tak paani ke saath li jaati hai24. Label ke hisaab se uske baad kam se kam 30 minute tak khana, peena ya doosri dawa nahi li jaati24.
Kya semaglutide wajan ghatane mein madad karta hai? India mein weight management ke liye semaglutide ka Wegovy injection approved hai, tablet nahi18. India mein semaglutide tablets sirf type 2 diabetes ke liye hain1,2,9. US label ke 26 hafte ke diabetes trial mein wajan average 2.3 kg (7 mg) aur 3.7 kg (14 mg) ghata, placebo par 1.4 kg24. Dekhein: semaglutide injection uses in Hindi.
Semaglutide ke kya side effects hain? Tablets mein sabse aam side effect nausea hai; dast, pet dard, ulti aur kabz bhi report hue24. Tirzepatide ke liye dekhein: Mounjaro injection kya hai.
Kya semaglutide tablets bina prescription mil sakti hain? Nahi. PharmEasy kehta hai ki India mein semaglutide ke sabhi brands, tablet ho ya injection, Schedule H prescription dawa hain3. Sarkar ne March 2026 mein kaha ki generic semaglutide sirf registered doctor ke prescription par bik sakta hai32. Dr Reddy's ki tablet ke liye CDSCO ki committee ne kaha ki ise sirf registered endocrinologist likhenge2.
Apni sehat aur dawa ke baare mein sawal ho to Zelta doctor se consultation book karein.
Sources
- CDSCO SEC (Endocrinology & Metabolism) minutes, 2023-08-22/23
- CDSCO SEC (Endocrinology & Metabolism) minutes, 2026-01-13
- PharmEasy, updated 2026-10-01 (pharmacy listing)
- PharmEasy, updated 2026-10-01 (pharmacy listing)
- Free Press Journal (PTI), 2026-07-09
- ET Pharma (The Economic Times), 'Dr Reddy's debuts semaglutide pill', May 2026 (page undated; fetch cut short)
- Wegovy US label (DailyMed, 2026-06-18)
- Business Today, 2026-02-20
- CDSCO SEC (Endocrinology & Metabolism) minutes, 2026-01-06
- Torrent Pharmaceuticals NSE filing, 2026-03-21
- Business Today, 2026-05-20
- Medical Dialogues, 2026-06-08
- Indian Pharma Post, 'Novo Nordisk India launches world's first and only GLP-1 RA, oral semaglutide', 2022-01-20
- Medical Dialogues, 'Wegovy Tablets for Weight Management: CDSCO Panel Seeks More Data from Novo Nordisk', 2026-10-21
- Foundayo (orforglipron) US label (DailyMed, 2026-07-29)
- CDSCO SEC (Endocrinology & Metabolism) minutes, 2026-06-24
- BioSpectrum India, 2026-03-21
- CDSCO SEC (Endocrinology & Metabolism) minutes, 2026-04-23
- The Week / PTI, 2025-03-20
- PharmEasy product page (Intra Labs), saved 2026-10-21 (undated page) (pharmacy listing)
- Glimepiride US label (DailyMed, 2026-09-28)
- Pharmacy Times, May 2026
- Leeds Community Healthcare NHS Trust, diabetes patient leaflet 'GLP-1 or GIP diabetes treatment' (page dated 2026-04-30)
- Rybelsus and Ozempic tablets US label (DailyMed, 2026-01-30)
- NHS medicines guide: semaglutide
- NHS, 'Low blood sugar (hypoglycaemia)' (read 2026-10-21)
- Government of Meghalaya, DIPR press release, 2026-05-27
- PIB backgrounder 'GLP-1 Drugs: Use, Risks, and Regulation', 2026-04-01
- NHS, 'Diarrhoea and vomiting' (page last reviewed 2023-12-21)
- Indian Pharmacopoeia Commission, PvPI FAQ (undated, read 2026-10-21)
- Indian Pharmacopoeia Commission, PvPI page (undated, read 2026-10-21)
- SuperKalam summary of the Indian Express, 2026-03-12
Medical Disclaimer
This article is for informational and educational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before starting, stopping, or changing any medication. The clinical trial results cited in this article reflect study averages from specific trial populations and may not predict individual outcomes. Drug availability, approved indications, and brand names vary by country and are subject to regulatory decisions by bodies such as the CDSCO in India, the FDA in the United States, and the EMA in Europe. Zelta does not endorse one medication over another. All treatment decisions are made by your prescribing clinician based on your individual health profile.